🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🏆🧪💊 The #FrontiersofKnowledge Award in the #Biology and #Biomedicine category goes to the four researchers who laid the biological foundations for revolutionary new treatments in #diabetes and #obesity Learn all about their contribution here: bbva.info/3WbRuRk

FDA approves acalabrutinib with bendamustine and rituximab for previously untreated mantle cell lymphoma fda.gov/drugs/resource…

📣 Busquem gerent/a 👉careers.carrerasresearch.org/jobs/5436365-v… 📊 Liderar l’organització administrativa i econòmica de l'Institut Josep Carreras ✅ Som centre d’Excel·lència #SeveroOchoa SOMM alliance part de la xarxa Centres CERCA i acreditat per Contra el Cáncer Investigación 🗓️ Termini: 31/01/2025

Happy to share the publication of our last work describing the safety and efficacy of #BRD4 and #EZH2 dual targeting in preclinical models of EZH2Y641mut B-cell lymphoma Roué Lab Josep Carreras Leukaemia Research Institute (IJC) sciencedirect.com/science/articl…

El fantástico equipo del Josep Carreras Leukaemia Research Institute (IJC), Dr. Gaël Roué Roué Lab publica un nuevo trabajo sobre el impacto de la inhibición simultánea de EZH2 y BRD4 en linfomas de células B germinales con mutación EZH2Y641. Y #AutoDiscovery aportando valor real. linkedin.com/posts/butler-s…

❗️🔬Dual targeting of MYC and EZH2 as a promising therapeutic strategy in Aggressive B Cell Lymphomas Do not miss the last work from Roué Lab lab! 👇

!THREE OPPORTUNITIES TO JOIN US! We are looking for 3 (!!!) PhD students interested in how Metabolism affects Genome Regulation. Join us at @carrerasIJC as @MSCAactions fellow. More info: 2 x experimental: nuclear-dn.eu 1 x computational: hubmol.eu

FDA approves brentuximab vedotin with lenalidomide and rituximab for relapsed or refractory large B-cell lymphoma fda.gov/drugs/resource…

Last week we were delighted to host Project Officer Oscar Barreiro-Mouriz from European Research Executive Agency for the Mid-term review at Josep Carreras Leukaemia Research Institute (IJC). ✨A great moment to reflect on our progress. 🔬The meeting was enriched with our #postdocs showcasing their innovative research. Marie Skłodowska-Curie Actions

“The End of the Golden Weather”: therapeutic strategies for mantle cell lymphoma relapsed or refractory to covalent BTK inhibitors | Haematologica haematologica.org/article/view/1…

Delighted to share the last results of our collaboration with the group of MS Rodriguez Laboratoire de chimie de coordination , describing the role of #TRIM24 in #MCL refractoriness to proteasome inhibition. A work co-authored by our great postdoc Núria Profitós Pelejà Roué Lab Josep Carreras Leukaemia Research Institute (IJC) nature.com/articles/s4142…

🔬🧬 New research —featuring Roué Lab lab— reveals hat reducing TRIM24 levels can overcome bortezomib resistance in mantle cell lymphoma, restoring drug sensitivity and opening new treatment possibilities. 👉 Read more at carrerasresearch.org/en/news/resear…

📢Call 4 is OPEN! Join the CarrerasLeaders program at Josep Carreras Leukaemia Research Institute (IJC)  for a 3-year postdoc. 📅 Apply by June 1, 2025 ✨World-class researchers supervision ✨International secondments ✨Top-tier research infrastructures More details at carrerasleaders.eu Marie Skłodowska-Curie Actions

🚨 Unique #Postdoc opportunity via Carreras Leaders! Join our team and lead cutting-edge research in #leukemia & #epigenetics. We're seeking passionate scientists eager to make an impact in leukemia research Josep Carreras Leukaemia Research Institute (IJC). 📩 Contact me to apply— and please RT! 🔁

We are pleased to announce that Dr Ari Melnick has been appointed new Director of the Josep Carreras Leukaemia Research Institute. Dr Melnick will lead IJC in our mission to advance #research in #leukaemia and other malignant blood diseases. Read the full release here:

The Josep Carreras Leukaemia Research Institute (IJC) team is having a blast at #AACR25 AACR presenting its research. Eduard Porta and Gaël Roué have shared their discoveries in #SpatialBiology and #Lymphoma, respectively.